July 08, 2025 a 03:43 pm
PFE: Fundamental Ratio Analysis - Pfizer Inc.
Pfizer Inc., a global leader in the pharmaceutical industry, is at the forefront of innovation in biopharmaceutical products. Despite the volatility in the market, Pfizer's stable performance and diverse product portfolio place it in a promising position for long-term growth.
Fundamental Rating
Pfizer Inc. demonstrates a balanced financial structure with a "B+" rating. Its consistent performance across various metrics suggests a stable investment opportunity with moderate growth expectations.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 3 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 4 |
Historical Rating
Reviewing past performance indicates consistent scoring, reflecting a stable financial profile amidst changing market dynamics.
| Date | Overall | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-07-07 | 3 | 5 | 3 | 4 | 1 | 2 | 4 |
| Historical | 0 | 5 | 3 | 4 | 1 | 2 | 4 |
Analyst Price Targets
Pfizer's price targets indicate a stable outlook, with all major metrics aligned, suggesting limited short-term volatility.
| High | Low | Median | Consensus |
|---|---|---|---|
| 24 | 24 | 24 | 24 |
Analyst Sentiment
Analyst recommendations solidify the 'Hold' consensus, reflecting balanced optimism and caution among market analysts.
| Recommendation | Count | Representation |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 15 | |
| Hold | 21 | |
| Sell | 1 | |
| Strong Sell | 0 |
Conclusion
Pfizer Inc. remains a solid investment option with a stable rating profile and consistent analyst recommendations supporting a 'Hold' consensus. The company's strong market presence and diverse product portfolio underpin its financial resilience. However, the limited variation in price targets indicates a period of potential stagnation. Investors should weigh the stable grounding against limited short-term growth potential.